Takayuki Fukuhara Selected Research

Takayuki Fukuhara Research Topics

Disease

20	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 03/2013
7	Neoplasm Metastasis (Metastasis) 09/2017 - 12/2014
6	Neoplasms (Cancer) 01/2021 - 03/2013
6	Chronic Hepatitis C 12/2020 - 10/2014
3	Infections 12/2020 - 05/2016
3	Fibrosis (Cirrhosis) 05/2016 - 07/2013
2	Liver Diseases (Liver Disease) 03/2021 - 03/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2016 - 06/2015
2	Non-alcoholic Fatty Liver Disease 03/2016 - 03/2014
2	Type 2 Diabetes Mellitus (MODY) 03/2016 - 03/2014
2	Thrombosis (Thrombus) 06/2015 - 06/2015
1	Diabetes Mellitus 03/2021
1	Thrombocytopenia (Thrombopenia) 03/2021
1	Fever (Fevers) 01/2021
1	Esophagitis 01/2021
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2020
1	Disease Progression 01/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Reinfection 03/2017
1	Hepatitis B 03/2017
1	Hand-Foot Syndrome 12/2016
1	Anemia 11/2016
1	Edema (Dropsy) 08/2016
1	Weight Loss (Weight Reduction) 03/2016
1	Disseminated Intravascular Coagulation 06/2015
1	Carcinoma (Carcinomatosis) 06/2015
1	Insulin Resistance 12/2014
1	Hepatitis C 12/2014
1	Pancreas Divisum 10/2014
1	Pancreatitis 10/2014
1	Cholestasis 08/2014
1	Acute Liver Failure (Fulminant Hepatic Failure) 08/2014
1	Erythropoietic Protoporphyria 08/2014
1	Brain Diseases (Brain Disorder) 07/2014

Drug/Important Bio-Agent (IBA)

7	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2013
5	Ribavirin (Virazole)FDA LinkGeneric 12/2020 - 10/2014
5	InterferonsIBA 11/2016 - 07/2013
3	Antiviral Agents (Antivirals)IBA 12/2020 - 08/2016
3	telaprevirIBA 12/2014 - 10/2014
2	lenvatinibIBA 01/2021 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 12/2014
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 05/2016
2	Tumor Biomarkers (Tumor Markers)IBA 09/2016 - 04/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2016 - 03/2014
1	Thrombopoietin ReceptorsIBA 03/2021
1	lusutrombopagIBA 03/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	regorafenibIBA 01/2021
1	Pemetrexed (MTA)FDA Link 01/2021
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2021
1	RamucirumabIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	velpatasvirIBA 12/2020
1	SofosbuvirIBA 12/2020
1	Cholinesterases (Cholinesterase)IBA 01/2020
1	Zoledronic Acid (Zometa)FDA Link 09/2017
1	hepatitis B hyperimmune globulinIBA 03/2017
1	DNA (Deoxyribonucleic Acid)IBA 03/2017
1	AntigensIBA 03/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2017
1	Immunoglobulins (Immunoglobulin)IBA 03/2017
1	Hemoglobins (Hemoglobin)IBA 11/2016
1	SimeprevirIBA 11/2016
1	daclatasvirIBA 08/2016
1	asunaprevirIBA 08/2016
1	CreatinineIBA 08/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2016
1	Hyaluronic Acid (Hyaluronan)IBA 03/2016
1	alogliptinIBA 03/2016
1	Triglycerides (Triacylglycerol)IBA 03/2016
1	Phospholipases (Phospholipase)IBA 03/2016
1	CholesterolIBA 03/2016
1	GadoliniumIBA 11/2015
1	Pentetic Acid (DTPA)FDA LinkGeneric 11/2015
1	AnticoagulantsIBA 06/2015
1	Dacarbazine (DIC)FDA LinkGeneric 06/2015
1	danaparoid (Orgaran)FDA Link 06/2015
1	Prothrombin (Factor II)IBA 12/2014
1	Interferon LambdaIBA 12/2014
1	Gabexate (Foy)IBA 10/2014
1	Heme (Haem)IBA 08/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2014
1	protoporphyrin IXIBA 08/2014
1	Transaminases (Aminotransferases)IBA 03/2014
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2014

Therapy/Procedure

13	Therapeutics 01/2021 - 06/2013
5	Drug Therapy (Chemotherapy) 09/2016 - 12/2013
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 07/2014 - 07/2013
1	Retreatment 12/2020
1	Nephrectomy 01/2019
1	Liver Transplantation 03/2017
1	Hepatectomy 12/2016
1	Drug Tapering 11/2016
1	Radiofrequency Ablation 08/2015
1	Conformal Radiotherapy 06/2015
1	Plasma Exchange 08/2014
1	Blood Transfusion (Blood Transfusions) 08/2014
1	Glycemic Control 03/2014